PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1784852
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1784852
Global Women's Digital Health Market to Reach US$9.4 Billion by 2030
The global market for Women's Digital Health estimated at US$3.0 Billion in the year 2024, is expected to reach US$9.4 Billion by 2030, growing at a CAGR of 20.8% over the analysis period 2024-2030. Mobile Apps, one of the segments analyzed in the report, is expected to record a 23.0% CAGR and reach US$4.8 Billion by the end of the analysis period. Growth in the Wearable Devices segment is estimated at 16.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$824.9 Million While China is Forecast to Grow at 27.6% CAGR
The Women's Digital Health market in the U.S. is estimated at US$824.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 27.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.3% and 18.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.7% CAGR.
Global Women’s Digital Health Market - Key Trends & Drivers Summarized
Women’s digital health is undergoing a transformation powered by technological advancements, personalized care, and an increasing focus on gender-specific medical needs. The intersection of healthcare and digital technology has led to an ecosystem where mobile applications, wearable devices, AI-driven diagnostics, and telemedicine play a crucial role in addressing female health concerns. From fertility tracking and pregnancy monitoring to menopause management and chronic disease prevention, digital health solutions tailored for women are expanding rapidly. The growing acceptance of femtech, a term coined to describe technology-driven healthcare solutions for women, has provided a major boost to innovation in this sector. Companies specializing in reproductive health, hormonal disorders, and mental well-being are leveraging artificial intelligence (AI), machine learning (ML), and big data analytics to create highly customized health solutions. Furthermore, remote healthcare models such as virtual consultations and digital therapeutics are making healthcare services more accessible, especially in underserved regions where women’s health infrastructure has historically been inadequate. The global push toward digital health records and integrated health systems also enhances efficiency in diagnosing and treating women’s health conditions. With the rise of digital biomarkers, women now have more control over their health data, allowing for proactive management of their reproductive and general health. This shift toward patient-centered healthcare is paving the way for improved outcomes, ensuring that digital technology is not just a convenience but a necessity for modern women’s health management.
The demand for femtech solutions has skyrocketed due to increasing awareness of women’s unique health challenges and the growing willingness of consumers to embrace digital healthcare tools. Historically, medical research and treatment models were largely male-centric, often overlooking crucial aspects of female physiology, leading to misdiagnosis and inadequate care. However, with the emergence of femtech, companies are addressing gender-specific concerns such as endometriosis, polycystic ovary syndrome (PCOS), and menstrual irregularities, which have long been underdiagnosed and undertreated. Startups and established health-tech firms are investing heavily in AI-powered menstrual tracking apps, digital contraceptives, and personalized hormonal health solutions, helping women better understand and manage their health. Moreover, the increasing prevalence of chronic conditions like osteoporosis, cardiovascular diseases, and autoimmune disorders-conditions that disproportionately affect women-is fueling the need for digital interventions tailored to female patients. Mental health platforms focusing on postpartum depression, anxiety, and perimenopausal mood disorders are gaining significant traction, underscoring the necessity of targeted solutions. Additionally, workplace wellness programs are incorporating digital health services for women, acknowledging that female employees have distinct healthcare requirements that directly impact productivity and well-being. The expansion of femtech beyond reproductive health into broader areas such as cardiovascular health, nutrition, and preventative care further cements its relevance. As women take a more proactive role in their healthcare decisions, the market for digital solutions specifically designed for them is poised for sustained growth, bridging long-standing gaps in traditional healthcare models.
Artificial intelligence and predictive analytics are reshaping the women’s digital health market, offering more accurate diagnoses, early detection of diseases, and personalized treatment plans. AI-powered diagnostic tools are proving particularly effective in detecting conditions such as cervical cancer, breast cancer, and gestational diabetes earlier than traditional methods. By analyzing vast amounts of patient data, AI enables early intervention strategies, reducing long-term health risks for women. In reproductive health, AI is transforming fertility treatments through advanced ovulation tracking, precision medicine, and embryo selection in in-vitro fertilization (IVF). AI chatbots and virtual health assistants are also playing a critical role in providing real-time medical guidance, symptom tracking, and mental health support, reducing the burden on healthcare providers while empowering women to take charge of their health. Furthermore, wearable devices equipped with AI-driven algorithms can monitor menstrual cycles, detect hormonal imbalances, and even predict pregnancy complications, offering real-time alerts for potential health risks. The rise of AI-driven personalized medicine ensures that treatments for conditions such as endometriosis and menopause are tailored to individual genetic and physiological profiles, enhancing efficacy and reducing side effects. As regulatory bodies increasingly approve digital therapeutics and AI-based medical solutions, the credibility and adoption of such innovations are expected to rise. With AI’s ability to process large datasets and recognize patterns, digital women’s health solutions are becoming more intuitive, predictive, and preventive, paving the way for smarter and more efficient healthcare management.
The growth in the women’s digital health market is driven by several factors, primarily the increasing demand for personalized healthcare, the widespread adoption of smartphones and wearable technology, and the rising influence of AI and big data in medical decision-making. One of the key drivers is the growing awareness among women regarding their health needs and their preference for non-invasive, data-driven, and self-managed healthcare solutions. The rise of telehealth and remote patient monitoring has made healthcare more accessible, particularly for women in rural and underserved areas who may face geographical or societal barriers to traditional medical care. Another critical factor is the expanding role of regulatory approvals and investments in femtech, with venture capital firms recognizing the potential of women-centric health solutions. As companies gain more funding, research in areas such as digital contraception, hormone tracking, and AI-powered diagnostics continues to evolve. The increasing integration of digital health platforms with insurance providers and employers’ healthcare benefits programs is further accelerating adoption, making these solutions more affordable and mainstream. Moreover, shifting demographics, including an aging female population with higher healthcare needs, are fueling demand for menopause-related digital health interventions. The growing emphasis on mental health, particularly concerning postpartum depression and perimenopausal anxiety, has also encouraged the adoption of digital therapeutic solutions tailored for women. The market is also benefitting from policy-level support, as governments and health organizations prioritize gender-specific healthcare research and digital innovation. With rapid advancements in wearable tech, machine learning, and cloud-based health services, the women’s digital health market is set to witness exponential growth, offering unprecedented opportunities for both businesses and consumers alike.
SCOPE OF STUDY:
The report analyzes the Women's Digital Health market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Mobile Apps, Wearable Devices, Diagnostic Tools, Others); Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic Care, General Healthcare & Wellness)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 34 Featured) -
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.